Science Resources RSS Feeds
|
 |
 |
 |
Cancer-causing Agents Current Events | Cancer-causing Agents News
|
| Page
1 of
129 |
2565 Results |
|
|
|
Sort By:
Page Views | Date |
Targeting Tumor Behavior May Lead To New Liver Cancer Drugs
Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. view more (2009-06-19)
Fat transforms vitamin C from 'good cop' into 'bad cop'
Fat in the stomach may cause vitamin C to promote, rather than prevent, the formation of certain cancer causing chemicals, reveals research published ahead of print in the journal Gut. view more (2007-09-04)
Researchers Discover New Method to Treat Cancer
Research at Oxford University's Institute of Molecular Medicine has identified a novel therapeutic regimen for the treatment of cancer that provides significant advantages over the existing methods of cancer treatment. There are already a number of regimens available for treatment of cancer, including chemotherapy, which is commonly used to treat... view more... (2003-03-20)
Sibling study could lead to better treatments for inherited form of colon cancer
Researchers at Huntsman Cancer Institute (HCI) believe they may be one step closer to understanding how certain forms of colon cancer develop. view more (2008-11-04)
New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks
A drug that targets the cell surface receptors that play an important role in many types of cancer can bring about significant tumour regression in breast cancer after only six weeks of use. view more (2008-04-17)
New information about DNA repair mechanism could lead to better cancer drugs
Researchers at Washington University School of Medicine in St. Louis have shed new light on a process that fixes breaks in the genetic material of the body's cells. view more (2009-07-17)
Adverse reactions from gadolinium-based contrast agents used during MRI rarely occur, study suggests
Acute adverse reactions from gadolinium-based contrast agents used during magnetic resonance imaging (MRI) to help improve the information seen on the images rarely occur, according to a study published in the February issue of the American Journal of Roentgenology. view more (2010-01-22)
Air pollution may increase lung cancer risk
Chronic air pollution may increase the risk of lung cancer, suggests a Norwegian study of over 16,000 men in Thorax. Researchers monitored the health of 16, 209 men from 1972 until 1998. The men, all of whom lived in Oslo, were taking part in long term research on risk factors for heart disease and stroke. They were aged between 40 and 49 at the... view more... (2003-12-03)
UC Davis researchers discover genetic switch involved in cells' response to radiation therapy
UC Davis Cancer Center researchers have discovered a genetic switch that causes cancer cells to become more sensitive to a drug administered to enhance radiation therapy effectiveness. view more (2005-11-17)
New compound may protect against liver cancer
Researchers have identified a new compound called CDDO-Im that protects against the development of liver cancer in laboratory animals. view more (2006-02-15)
Statin therapy ineffective in breast cancer prevention
Laboratory work in animals showed limited activity when statins were given to prevent breast cancer, according to a report in the February issue of Cancer Prevention Research, a journal of the American Association for Cancer Research. view more (2009-02-05)
This idea doesn't stink: New tech cuts industrial odors, pollutants
A North Carolina State University researcher has devised a new technology that really does not stink. In fact, it could be the key to eliminating foul odors and air pollutants emitted by industrial chicken rendering facilities and - ultimately - large-scale swine feedlots. view more (2009-08-27)
Chemotherapy causes delayed severe neural damage
Cancer treatment with chemotherapeutic agents is often associated with delayed adverse neurological consequences - an occurrence often referred to as "chemobrain" - that may compromise the quality of life of a proportion of cancer survivors. view more (2008-04-22)
Synergistic growth inhibitory effect of herbal extracts against HCC and lung cancer cells
Several herbs with diversified pharmacological properties are known to be rich sources of chemical constituents that may have potential for the treatment of several human cancers. Data from the Department of Preclinical Science, Faculty of Medicine, Thammasat University, demonstrates that the growth inhibitory activity of doxorubicin or cisplatin,... view more... (2008-04-30)
Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer
Researchers at the University of Pennsylvania School of Medicine and Abramson Cancer Center reported today at the annual meeting of the American Association for Cancer Research that combining two targeted therapies overcomes treatment resistance in liver cancer cell lines. The team is currently designing a trial to test the combination in patients. view more (2008-04-14)
VEGF Trap shows activity in patients with advanced ovarian cancer
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. view more (2007-06-04)
Newer contrast agents safe for children
Allergic-like reactions to newer iodine-containing contrast agents (nonionic contrast media), are rare in children according to a recent study conducted by researchers from the University of Michigan Medical Center and C.S. Mott Children's Hospital both in Ann Arbor. view more (2007-06-08)
Researchers discover link between organ transplantation and increased cancer risk
Researchers have determined a novel mechanism through which organ transplantation often leads to cancer, and their findings suggest that targeted therapies may reduce or prevent that risk. view more (2008-07-16)
U of Saskatchewan distinguished researcher finds an SOS response to cancer-causing agents
University of Saskatchewan microbiologist Wei Xiao has found a way to trigger a protein combination called 9-1-1 that sends an SOS signal for cells to fight cancer-causing agents such as industrial toxins, ultraviolet radiation, and X-rays. view more (2008-05-16)
Comment from Professor Nick Lemoine, Director of Imperial Cancer Research Fund's Molecular Oncology Unit at the Hammersmith Hospital, in response to US research* that has linked breast cancer to a virus:
Comment from Professor Nick Lemoine, Director of Imperial Cancer Research Fund's Molecular Oncology Unit at the Hammersmith Hospital, in response to US research* that has linked breast cancer to a virus: view more (1999-08-11)
|
|
| Page
1 of
129 |
2565 Results |
|
|
|
Sort By:
Page Views | Date |
|
|
